Modus Therapeutics Holding AB - ESG Rating & Company Profile powered by AI
If you are employed by Modus Therapeutics Holding AB and you would like to use your ESG rating, please contact us. This assessment of Modus Therapeutics Holding AB incorporates data from across the web as well as from available disclosures by Modus Therapeutics Holding AB. This ESG score includes seventeen UN Sustainable Development Goals including: 'Quality Education', 'Reduced Inequalities' and 'Life on Land'.
Modus Therapeutics Holding AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 4.0, social score of 5.3 and governance score of 8.0.
5.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 521 | Smruthi Organics Ltd | 5.9 | High |
| 521 | Vectura Group PLC | 5.9 | High |
| 541 | Modus Therapeutics Holding AB | 5.8 | High |
| 541 | Cantargia AB | 5.8 | High |
| 541 | Amplia Therapeutics Ltd | 5.8 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Modus Therapeutics Holding AB have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose current and historical energy intensity?
Sign up for free to unlockDoes Modus Therapeutics Holding AB report the average age of the workforce?
Sign up for free to unlockDoes Modus Therapeutics Holding AB reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose its ethnicity pay gap?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose cybersecurity risks?
Sign up for free to unlockDoes Modus Therapeutics Holding AB offer flexible work?
Sign up for free to unlockDoes Modus Therapeutics Holding AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Modus Therapeutics Holding AB conduct supply chain audits?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Modus Therapeutics Holding AB conduct 360 degree staff reviews?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose the individual responsible for D&I?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose water use targets?
Sign up for free to unlockDoes Modus Therapeutics Holding AB have careers partnerships with academic institutions?
Sign up for free to unlockDid Modus Therapeutics Holding AB have a product recall in the last two years?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose incidents of discrimination?
Sign up for free to unlockDoes Modus Therapeutics Holding AB allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Modus Therapeutics Holding AB issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose parental leave metrics?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose the pay ratio of women to men?
Sign up for free to unlockDoes Modus Therapeutics Holding AB support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Modus Therapeutics Holding AB reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Modus Therapeutics Holding AB involved in embryonic stem cell research?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose its waste policy?
Sign up for free to unlockDoes Modus Therapeutics Holding AB report according to TCFD requirements?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose energy use targets?
Sign up for free to unlockDoes Modus Therapeutics Holding AB disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Modus Therapeutics Holding AB have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Modus Therapeutics Holding AB
These potential risks are based on the size, segment and geographies of the company.
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.